IN2014MN00144A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN00144A IN2014MN00144A IN144MUN2014A IN2014MN00144A IN 2014MN00144 A IN2014MN00144 A IN 2014MN00144A IN 144MUN2014 A IN144MUN2014 A IN 144MUN2014A IN 2014MN00144 A IN2014MN00144 A IN 2014MN00144A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161505685P | 2011-07-08 | 2011-07-08 | |
PCT/US2012/045254 WO2013009517A1 (en) | 2011-07-08 | 2012-07-02 | (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN00144A true IN2014MN00144A (ko) | 2015-06-19 |
Family
ID=46513872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN144MUN2014 IN2014MN00144A (ko) | 2011-07-08 | 2014-01-23 |
Country Status (22)
Country | Link |
---|---|
US (1) | US9481688B2 (ko) |
EP (1) | EP2729474B1 (ko) |
JP (1) | JP6050813B2 (ko) |
KR (1) | KR101582429B1 (ko) |
CN (1) | CN103703008B (ko) |
AU (1) | AU2012283035B2 (ko) |
BR (1) | BR112014000379A2 (ko) |
CA (1) | CA2840217C (ko) |
DK (1) | DK2729474T3 (ko) |
EA (1) | EA023460B1 (ko) |
ES (1) | ES2665035T3 (ko) |
HR (1) | HRP20180475T1 (ko) |
HU (1) | HUE037649T2 (ko) |
IN (1) | IN2014MN00144A (ko) |
LT (1) | LT2729474T (ko) |
MX (1) | MX341132B (ko) |
NO (1) | NO2729474T3 (ko) |
PL (1) | PL2729474T3 (ko) |
PT (1) | PT2729474T (ko) |
RS (1) | RS57207B1 (ko) |
SI (1) | SI2729474T1 (ko) |
WO (1) | WO2013009517A1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015015491A8 (pt) * | 2013-01-14 | 2018-01-23 | Lilly Co Eli | (tieno[2,3-b][1,5] benzoxazepin-4-il) piperazin-1-ila, seus usos, e composição farmacêutica. |
TW201625644A (zh) | 2014-04-29 | 2016-07-16 | 美國禮來大藥廠 | 作為選擇性5-HTA反向促效劑之(噻吩并[2,3-b][1,5]苯并氧氮呯-4-基)哌嗪-1-基化合物 |
WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
CN108371660B (zh) * | 2017-12-14 | 2020-03-10 | 五邑大学 | 一种四氢环戊二烯并吡咯化合物及其衍生物的用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602124A (en) * | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | 5-HT2 receptor ligands |
US6828332B1 (en) * | 1999-09-29 | 2004-12-07 | Eli Lilly And Company | Piperidine derivatives as reuptake inhibitors |
HU226410B1 (en) * | 2003-04-22 | 2008-11-28 | Egis Gyogyszergyar Nyilvanosan | Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them |
US7807828B2 (en) * | 2005-08-11 | 2010-10-05 | Hypnion, Inc. | Olanzapine analogs and methods of use thereof |
BRPI0808828A8 (pt) * | 2007-03-15 | 2017-11-28 | Aryx Therapeutics Inc | Compostos de dibenzo[b,f][1,4]oxazapina |
CN105168219B (zh) * | 2008-05-27 | 2018-11-20 | 细胞内治疗公司 | 用于睡眠障碍和其他疾病的方法和组合物 |
GB0910009D0 (en) * | 2009-06-10 | 2009-07-22 | Glaxo Group Ltd | Novel compounds |
AR084867A1 (es) * | 2011-02-07 | 2013-07-10 | Lilly Co Eli | Compuestos de acido [(5h-pirrolo[2,1-c][1,4]benzodiazepin-11-il)piperazin-1-il]-2,2-dimetilpropanoico sustituido como antagonistas de 5-ht/agonistas inversos de actividad dual |
BR112014004557A2 (pt) * | 2011-08-30 | 2017-05-30 | Lilly Co Eli | compostos (tieno[2,3-b][1,5]benzoxazepin-4-il)piperazin-1-ila como agonistas inversos de h1/antagonistas de 5-ht2a de dupla atividade |
-
2012
- 2012-07-02 CA CA2840217A patent/CA2840217C/en not_active Expired - Fee Related
- 2012-07-02 SI SI201231263T patent/SI2729474T1/en unknown
- 2012-07-02 KR KR1020147000119A patent/KR101582429B1/ko active IP Right Grant
- 2012-07-02 EP EP12735409.0A patent/EP2729474B1/en active Active
- 2012-07-02 RS RS20180568A patent/RS57207B1/sr unknown
- 2012-07-02 US US14/125,320 patent/US9481688B2/en active Active
- 2012-07-02 PL PL12735409T patent/PL2729474T3/pl unknown
- 2012-07-02 WO PCT/US2012/045254 patent/WO2013009517A1/en active Application Filing
- 2012-07-02 NO NO12735409A patent/NO2729474T3/no unknown
- 2012-07-02 CN CN201280031201.7A patent/CN103703008B/zh active Active
- 2012-07-02 JP JP2014519227A patent/JP6050813B2/ja active Active
- 2012-07-02 DK DK12735409.0T patent/DK2729474T3/en active
- 2012-07-02 EA EA201391706A patent/EA023460B1/ru not_active IP Right Cessation
- 2012-07-02 BR BR112014000379A patent/BR112014000379A2/pt not_active IP Right Cessation
- 2012-07-02 ES ES12735409.0T patent/ES2665035T3/es active Active
- 2012-07-02 AU AU2012283035A patent/AU2012283035B2/en not_active Ceased
- 2012-07-02 PT PT127354090T patent/PT2729474T/pt unknown
- 2012-07-02 LT LTEP12735409.0T patent/LT2729474T/lt unknown
- 2012-07-02 HU HUE12735409A patent/HUE037649T2/hu unknown
- 2012-07-02 MX MX2014000337A patent/MX341132B/es active IP Right Grant
-
2014
- 2014-01-23 IN IN144MUN2014 patent/IN2014MN00144A/en unknown
-
2018
- 2018-03-21 HR HRP20180475TT patent/HRP20180475T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CN103703008B (zh) | 2015-11-25 |
HUE037649T2 (hu) | 2018-09-28 |
PL2729474T3 (pl) | 2018-08-31 |
US20140121199A1 (en) | 2014-05-01 |
EP2729474A1 (en) | 2014-05-14 |
HRP20180475T1 (hr) | 2018-06-15 |
JP6050813B2 (ja) | 2016-12-21 |
BR112014000379A2 (pt) | 2017-01-10 |
KR101582429B1 (ko) | 2016-01-04 |
CA2840217C (en) | 2016-03-22 |
DK2729474T3 (en) | 2018-05-22 |
MX2014000337A (es) | 2014-11-13 |
CA2840217A1 (en) | 2013-01-17 |
AU2012283035B2 (en) | 2015-07-30 |
LT2729474T (lt) | 2018-05-10 |
EA023460B1 (ru) | 2016-06-30 |
KR20140029512A (ko) | 2014-03-10 |
AU2012283035A1 (en) | 2014-01-16 |
RS57207B1 (sr) | 2018-07-31 |
US9481688B2 (en) | 2016-11-01 |
CN103703008A (zh) | 2014-04-02 |
ES2665035T3 (es) | 2018-04-24 |
WO2013009517A1 (en) | 2013-01-17 |
EA201391706A1 (ru) | 2014-04-30 |
PT2729474T (pt) | 2018-06-05 |
EP2729474B1 (en) | 2018-03-14 |
SI2729474T1 (en) | 2018-04-30 |
MX341132B (es) | 2016-08-09 |
NO2729474T3 (ko) | 2018-08-11 |
JP2014518280A (ja) | 2014-07-28 |